DK100487A - Hidtil ukendte carbonsyrederivater, fremgangsmaade til deres fremstilling, deres anvendelse samt laegemidler indeholdende disse forbindelser - Google Patents

Hidtil ukendte carbonsyrederivater, fremgangsmaade til deres fremstilling, deres anvendelse samt laegemidler indeholdende disse forbindelser

Info

Publication number
DK100487A
DK100487A DK100487A DK100487A DK100487A DK 100487 A DK100487 A DK 100487A DK 100487 A DK100487 A DK 100487A DK 100487 A DK100487 A DK 100487A DK 100487 A DK100487 A DK 100487A
Authority
DK
Denmark
Prior art keywords
acid derivatives
relationships
procedures
preparation
pct
Prior art date
Application number
DK100487A
Other languages
English (en)
Other versions
DK100487D0 (da
Inventor
Hans Peter Wolff
Ernst-Christian Witte
Hans-Frieder Kuehnle
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK100487D0 publication Critical patent/DK100487D0/da
Publication of DK100487A publication Critical patent/DK100487A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/88Unsaturated compounds containing keto groups containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK100487A 1985-07-16 1987-02-26 Hidtil ukendte carbonsyrederivater, fremgangsmaade til deres fremstilling, deres anvendelse samt laegemidler indeholdende disse forbindelser DK100487A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853525284 DE3525284A1 (de) 1985-07-16 1985-07-16 Neue carbonsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie arzneimittel, die diese verbindungen enthalten
PCT/EP1986/000406 WO1987000521A2 (fr) 1985-07-16 1986-07-10 Nouveaux derives d'acide carboxylique, leur procede de fabrication, leur utilisation, et medicaments contenant ces composes

Publications (2)

Publication Number Publication Date
DK100487D0 DK100487D0 (da) 1987-02-26
DK100487A true DK100487A (da) 1987-02-26

Family

ID=6275845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK100487A DK100487A (da) 1985-07-16 1987-02-26 Hidtil ukendte carbonsyrederivater, fremgangsmaade til deres fremstilling, deres anvendelse samt laegemidler indeholdende disse forbindelser

Country Status (21)

Country Link
US (1) US4933367A (da)
EP (1) EP0226636B1 (da)
JP (1) JPS63500310A (da)
KR (1) KR870700599A (da)
AT (1) ATE40681T1 (da)
AU (2) AU595814B2 (da)
CA (1) CA1316922C (da)
DD (1) DD254193A5 (da)
DE (2) DE3525284A1 (da)
DK (1) DK100487A (da)
ES (1) ES2001163A6 (da)
FI (1) FI871143A0 (da)
GR (1) GR861803B (da)
IL (1) IL79379A0 (da)
NO (1) NO166939C (da)
NZ (1) NZ216830A (da)
PH (1) PH25313A (da)
PT (1) PT82987B (da)
SU (1) SU1708156A3 (da)
WO (1) WO1987000521A2 (da)
ZA (1) ZA865192B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910002674B1 (ko) * 1986-05-29 1991-05-03 이 아이 듀우판 디 네모아 앤드 캄파니 실릴케텐 아세탈의 아실화
DE3700729A1 (de) * 1987-01-13 1988-07-21 Boehringer Mannheim Gmbh Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE3935512A1 (de) * 1989-10-25 1991-05-02 Boehringer Mannheim Gmbh Neues herstellungsverfahren fuer verbindungen mit wertvollen pharmakologischen eigenschaften sowie neue zwischenprodukte zur herstellung dieser verbindungen
DE4112103C2 (de) * 1991-02-18 1994-07-14 Matthias Mueller Verwendung von Essigsäure zur Regulierung der Blutzuckerwerte
JP2785162B2 (ja) * 1991-04-05 1998-08-13 富士写真フイルム株式会社 写真用ポリエステル支持体およびハロゲン化銀写真感光材料
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
HRP950558A2 (en) * 1994-11-15 1997-12-31 Scott M. Wilhelm Substituted 4-biarylbutric or biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
US6197791B1 (en) 1997-02-27 2001-03-06 American Cyanamid Company N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6262118B1 (en) 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US7576131B2 (en) * 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US6720450B2 (en) 2001-12-13 2004-04-13 North Carolina State University Pesticidal activity of functionalized cyclopropanes
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
AU2005247473A1 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Substituted triazoles as modulators of PPAR and methods of their preparation
WO2005115384A2 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
CA2702468A1 (en) * 2007-10-12 2009-04-23 University Of Connecticut Therapeutic applications of fatty acid amide hydrolase inhibitors
CN114075106B (zh) * 2020-08-12 2023-09-12 广东省稀有金属研究所 一种脂肪醇醚羧酸的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562330A (en) 1968-07-18 1971-02-09 Parke Davis & Co 2-phenoxy-4- and 5-phenyl-butyl and -pentyl-amines and salts
BE760034A (fr) * 1969-12-08 1971-06-08 Ici Ltd Production d'esters
GB1382267A (en) * 1970-05-05 1975-01-29 Rorer Inc William H Phenylalkanoic acid derivatives
DE3063144D1 (en) * 1979-09-07 1983-06-16 Byk Gulden Lomberg Chem Fab Substituted oxirane carboxylic acids, process for their preparation, their use and medicines containing them

Also Published As

Publication number Publication date
SU1708156A3 (ru) 1992-01-23
FI871143A7 (fi) 1987-03-16
NO166939B (no) 1991-06-10
US4933367A (en) 1990-06-12
NZ216830A (en) 1990-11-27
DE3525284A1 (de) 1987-01-29
EP0226636B1 (de) 1989-02-08
ATE40681T1 (de) 1989-02-15
PH25313A (en) 1991-04-30
NO871059D0 (no) 1987-03-13
IL79379A0 (en) 1986-10-31
WO1987000521A3 (en) 1987-03-12
DK100487D0 (da) 1987-02-26
PT82987B (pt) 1988-07-01
AU5988086A (en) 1987-01-22
DD254193A5 (de) 1988-02-17
NO166939C (no) 1991-09-18
WO1987000521A2 (fr) 1987-01-29
FI871143A0 (fi) 1987-03-16
DE3662041D1 (en) 1989-03-16
KR870700599A (ko) 1987-12-30
GR861803B (en) 1986-11-10
PT82987A (de) 1986-08-01
NO871059L (no) 1987-03-13
AU595814B2 (en) 1990-04-12
AU6194286A (en) 1987-02-10
ZA865192B (en) 1987-03-25
EP0226636A1 (de) 1987-07-01
JPS63500310A (ja) 1988-02-04
ES2001163A6 (es) 1988-05-01
CA1316922C (en) 1993-04-27

Similar Documents

Publication Publication Date Title
DK100487D0 (da) Hidtil ukendte carbonsyrederivater, fremgangsmaade til deres fremstilling, deres anvendelse samt laegemidler indeholdende disse forbindelser
DK552684A (da) Desulfatohirudiner samt deres fremstilling og anvendelse
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
NO885213L (no) Stabiliserte legemidler, fremgangsmaate til deres fremstilling samt stabile legemiddeltilberedninger.
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
DK579185A (da) Pyrrolobenzimidazoler, fremgangsmaade til fremstilling heraf samt laegemidler med indhold heraf
NO882207L (no) Blandingskrystaller av insulin og insulinderivater, fremg. til fremst. av disse blandingskrystaller, farmasoeytiske midler som inneholder disse blandingskrystaller og deres anvendelse til behandling av diabetes mellitus.
GB8727099D0 (en) Compositions containing melantonin/homologues
DK319484A (da) Imidazol-2-ylthioalkansyrer, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DK383388D0 (da) 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling
DK161313C (da) 4-(bis-fluorphenylbutyl)-1-(pyridyl- eller pyrimidinyl)-piperazin- eller -1,4-diazabicycloheptanforbindelser, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse samt anvendelse af forbindelserne
ATE81976T1 (de) 2-pyrimidinyl-1-piperazin-derivate zur behandlung von alkoholismus.
DK418986A (da) Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
DK319384A (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
ATE60906T1 (de) Pharmazeutisches produkt enthaltend ein gemisch aus benzoesaeure, phenol und ein alkalifluorid zur topischen behandlung von herpes-viruseffluoreszenzen.
FI883455A0 (fi) Leukotrienantagonister, foerfaranden foer deras framstaellning, deras anvaendning vid behandling av sjukdomar samt foerprodukter.
DK314587A (da) 1,4-dihydropyridinderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser
DK98788A (da) Benzylaminoaryl-dihydropyridinlactoner, fremgangmsaade til deres fremstilling samt deres anvendelse som laegemidler

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment